Professor
Feinberg School of Medicine, Northwestern University
Chicago, Illinois, United States
Dr. Tan is Professor of Pediatrics at the Feinberg School of Medicine, Northwestern University, and a Pediatric Infectious Diseases attending; Medical Director of the International Patient Services Program (IPS); co-Director of the Pediatric Travel Medicine Clinic; and Director of the International Adoptee Clinic at Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois. She is board certified in Pediatrics and Pediatric Infectious Diseases.
Dr. Tan is a member of the Board of Directors of the Infectious Diseases Society of America (IDSA). She also is a member of the IDSA Education Committee and the chairperson of the IDSA Task Force on Diversity, Inclusion, Access & Equity. She has served as Chairperson of the American Academy of Pediatrics (AAP) Section on Infectious Diseases (SOID – 2014-2018) and as a member of the AAP Committee on Infectious Diseases (COID – Redbook Committee – 2010 - 2018). She currently serves as a member of the: AAP Global Immunization Advocacy Project Advisory Committee and is a Technical Advisor for the AAP/CDC Global Immunization Advocacy Project, the AAP Antimicrobial Resistance and Stewardship Workgroup – Education Subcommittee, AAP Expert Pertussis Cocooning Advisory Committee, and is a liaison to the CDC ACIP Pertussis Working Group and to the Illinois Chapter of the AAP OB/GYN Immunizations and Pregnancy Outreach Committee. She is a member of the American Board of Pediatrics Global Health Task Force Dissemination and Advocacy Work Group. Dr. Tan is a member of: the Advisory Commission on Childhood Vaccines of the US Department of Health and Human Services, the NIH/NIAID Clinical Trial Planning and Implementation Grant Review Panel, and the Vaccine and Related Biologic Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA).
She serves on the editorial boards of: the Journal of the Pediatric Infectious Diseases Society (Official Journal of the Pediatric Infectious Diseases Society - PIDS), and Internal Medicine Reviews.
She is the Co-Chairperson and US Representative to the International Steering Committee of the Global Pertussis Initiative (GPI); a member and consultant to the Steering Committee of the Latin America Without Pertussis Initiative (PAHEF, SLIPE); a member of the Board of Directors of the World Association of Infectious Diseases and Immunological Disorders (WAidid), and a member of the US National Pertussis Task Force (AAP and Every Child by Two). She also is a member of the vaccine advisory boards of Merck, Sanofi Pasteur, GSK and Pfizer/Wyeth.
Her interests include: pertussis disease and vaccine, pneumococcal disease and vaccine, CA-MRSA infections, antibiotic resistance, vaccines and vaccine preventable diseases, general infectious diseases, and vaccine education for healthcare providers.
Disclosure(s): Astra Zeneca: Grant/Research Support; GSK: Grant/Research Support; Iliad: Advisor/Consultant; Merck: Advisor/Consultant; Moderna: Advisor/Consultant; Novavax: Advisor/Consultant; Pfizer: Advisor/Consultant; Sanofi Pasteur: Advisor/Consultant
Saturday, October 19, 2024
12:40 PM – 12:45 PM US PT